At the Detroit Auto Show, I had the great pleasure of attending with Jeep. I was there during the Press Only days and attending the unveiling new Compass, the Jeep Grand Cherokee EcoDiesel (diesel) and the Jeep Grand Cherokee SRT. After the press conference I was talking with people that work for Jeep. One of the Jeep Executives said that because they drive a Jeep and work at Jeep weather is not an excuse to not come into work. LOL. awesome. Its a Jeep. This was shot at the North American International Auto Show aka NAIAS. Twitter: https://twitter.com/AntonStetner . Facebook: http://www.facebook.com/LifeOfAnton . Pinterest: http://pinterest.com/antonstetner/ . Instagram: @antonstetner . Flickr: http://www.flickr.com/antonstetner/
ATC Global reaffirms its position as the place to do business for the international ATM community with the release of exclusive video footage from last month’s event.
The videos further demonstrate the unique position of ATC Global within the international ATM market, showcasing the quality, diversity and geographical reach of its attendee base alongside the delivery of a world-class, content-rich education programme.
To view Multimedia News Release, go to http://www.multivu.com/mnr/60643-ATC-global-2013-confirmed-exclusive-video
Researchers presenting at ASTRO 2015, the premier radiation oncology scientific event in the world, unveiled new data this week that could fundamentally change the way that early stage breast cancer is treated.
Results from a landmark prospective, randomized, multicenter phase III study conducted in Europe demonstrated that APBI brachytherapy leads to equivalent overall survival and local cancer control rates as compared to WBI after breast conserving surgery for selected patients with early stage breast cancers. These data were presented during the ASTRO official press conference and published in The Lancet, a leading high-impact global peer-reviewed medical journal.
“We have been confidently offering APBI brachytherapy to selected women for years based on numerous phase II, single site and large registry studies that have confirmed the clinical utility of site-specific radiation delivered in a condensed timeframe,” said Frank A. Vicini, M.D., radiation oncologist, 21st Century Oncology, Royal Oak, Mich. and contributing author to the 2009 and 2013 ASTRO and ABS APBI guidelines. “The results from this landmark, multicenter, prospective randomized clinical study are the first to offer the critical level one evidence necessary to drive the fundamental changes in breast conserving cancer treatment that patients and healthcare professionals have been demanding for years.”
To view the multimedia release go to:
http://www.multivu.com/players/uk/7661231-new-apbi-brachytherapy-data-at-astro-2015/
For negotiators at the Paris climate conference (COP21) to successfully advance global efforts to reduce carbon emissions, nations must embrace a prominent role for nuclear energy.
The Obama administration highlighted the crucial role of nuclear energy when it convened a White House Summit on Nuclear Energy earlier this month. “As America leads the global transition to a low-carbon economy, the continued development of new and advanced nuclear technologies along with support for currently operating nuclear power plants is an important component of our clean energy strategy,” a White House fact sheet developed for the summit states. Many environmentalists are also giving nuclear energy a second look, as they seek practical solutions to constrain carbon emissions.
Nuclear energy facilities provide 63 percent of America’s zero-carbon electricity. Globally, nuclear power plants provide one-third of all zero-carbon electricity. One of nuclear energy’s major advantages relative to other low-carbon energy sources is its unique ability to produce large-scale electricity around-the-clock in extreme weather conditions. Nuclear energy facilities don’t rely on the wind blowing, the sun shining, or just-in-time deliveries of fuel by truck, barge, rail or pipeline. In 2014, the U.S. nuclear energy industry’s average capacity factor—a common measure of efficiency and reliability—was 92 percent.
To view the multimedia release go to:
http://www.multivu.com/players/English/7694251-nuclear-energy-cop21-climate-goals/
Celebrity Chef Robert Irvine, host of Food Network’s Restaurant: Impossible, announced today that he is teaming up with Tropicana Las Vegas to open his first signature restaurant on the Las Vegas Strip. At the press conference, the exterior of the Tropicana Las Vegas came to life, where a high-energy video showed the crowd what they can expect to see from the newest chef in town. In true Robert Irvine fashion, the celebrity chef made his entrance by rappelling 22 stories (220 feet) down the exterior of the Tropicana hotel to the assembled press below.
In introducing Chef Irvine, Bob Sheldon, President of Las Vegas Operations for Tropicana’s parent company, Penn National Gaming, said, “Chef Robert Irvine has tackled some of the toughest culinary challenges around the world, and we’re excited to have him take on Las Vegas, right here at the Tropicana. We are thrilled to be the Las Vegas home to such an acclaimed world-class chef. With his unparalleled passion, energy and culinary skills, he is the perfect addition to our family.”
To view the multimedia release go to:
http://www.multivu.com/players/English/7838851-robert-irvine-tropicana-las-vegas/
Researchers presenting at ASTRO 2015, the premier radiation oncology scientific event in the world, unveiled new data this week that could fundamentally change the way that early stage breast cancer is treated.
Results from a landmark prospective, randomized, multicenter phase III study conducted in Europe demonstrated that APBI brachytherapy leads to equivalent overall survival and local cancer control rates as compared to WBI after breast conserving surgery for selected patients with early stage breast cancers. These data were presented during the ASTRO official press conference and published in The Lancet, a leading high-impact global peer-reviewed medical journal.
“We have been confidently offering APBI brachytherapy to selected women for years based on numerous phase II, single site and large registry studies that have confirmed the clinical utility of site-specific radiation delivered in a condensed timeframe,” said Frank A. Vicini, M.D., radiation oncologist, 21st Century Oncology, Royal Oak, Mich. and contributing author to the 2009 and 2013 ASTRO and ABS APBI guidelines. “The results from this landmark, multicenter, prospective randomized clinical study are the first to offer the critical level one evidence necessary to drive the fundamental changes in breast conserving cancer treatment that patients and healthcare professionals have been demanding for years.”
To view the multimedia release go to:
http://www.multivu.com/players/uk/7661231-new-apbi-brachytherapy-data-at-astro-2015/
Out of thousands of high achieving Kumon Students from the United States, Canada, and Mexico, just 56 were selected to attend the second annual Kumon Student Conference in Calgary, Canada on July 18th. The invited students are studying at least three years above their grade level in math and/or reading at their respective Kumon Centers.
Attendees had the opportunity to learn from each other through a variety of enjoyable learning activities designed to foster team building, group discussion, critical thinking and creativity. In this unique learning environment, students heard from inspirational former Kumon Students who have completed the Kumon Program, some of whom are now successful professionals.
To view the multimedia release go to:
https://www.multivu.com/players/English/8238651-kumon-holds-second-annual-student-conference/
Researchers presenting at ASTRO 2015, the premier radiation oncology scientific event in the world, unveiled new data this week that could fundamentally change the way that early stage breast cancer is treated.
Results from a landmark prospective, randomized, multicenter phase III study conducted in Europe demonstrated that APBI brachytherapy leads to equivalent overall survival and local cancer control rates as compared to WBI after breast conserving surgery for selected patients with early stage breast cancers. These data were presented during the ASTRO official press conference and published in The Lancet, a leading high-impact global peer-reviewed medical journal.
“We have been confidently offering APBI brachytherapy to selected women for years based on numerous phase II, single site and large registry studies that have confirmed the clinical utility of site-specific radiation delivered in a condensed timeframe,” said Frank A. Vicini, M.D., radiation oncologist, 21st Century Oncology, Royal Oak, Mich. and contributing author to the 2009 and 2013 ASTRO and ABS APBI guidelines. “The results from this landmark, multicenter, prospective randomized clinical study are the first to offer the critical level one evidence necessary to drive the fundamental changes in breast conserving cancer treatment that patients and healthcare professionals have been demanding for years.”
To view the multimedia release go to:
http://www.multivu.com/players/uk/7661231-new-apbi-brachytherapy-data-at-astro-2015/
Siam Piwat, the owner of Bangkok’s leading shopping malls, ,held a press conference to announce the countdown to the opening of the new Siam Center as a center and ‘ideaopolis’ where creative and world-leading trends can be explored. World famous celebrities, artists, and their work are assembling here in Bangkok for the opening of the new Siam Center on January the 11th.
“Preliminary forecast global sales for 2012 are just over $49 billion – close to the magic $50 billion which was discussed not all that many years ago as a possible figure to reach, but still a little away from the projected $64 billion by 2015. The 2012 result is a 7.5% increase on 2011 and, yet again, it’s the Asia Pacific region that is the powerhouse of this growth,” stated Erik Juul-Mortensen, President TFWA.
To view the Multimedia News Release, go to http://www.multivu.com/mnr/60631-tfwa
